PL2714034T3 - Kompozycje zawierające cefepim i tazobaktam - Google Patents

Kompozycje zawierające cefepim i tazobaktam

Info

Publication number
PL2714034T3
PL2714034T3 PL11761404T PL11761404T PL2714034T3 PL 2714034 T3 PL2714034 T3 PL 2714034T3 PL 11761404 T PL11761404 T PL 11761404T PL 11761404 T PL11761404 T PL 11761404T PL 2714034 T3 PL2714034 T3 PL 2714034T3
Authority
PL
Poland
Prior art keywords
tazobactam
cefepime
compositions
Prior art date
Application number
PL11761404T
Other languages
English (en)
Inventor
Sachin Subhash Bhagwat
Mohammad Alam Jafri
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Limited filed Critical Wockhardt Limited
Publication of PL2714034T3 publication Critical patent/PL2714034T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11761404T 2011-05-28 2011-08-01 Kompozycje zawierające cefepim i tazobaktam PL2714034T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1587MU2011 2011-05-28
PCT/IB2011/053398 WO2012164358A1 (en) 2011-05-28 2011-08-01 Compositions comprising antibacterial agent and tazobactam
EP11761404.0A EP2714034B1 (en) 2011-05-28 2011-08-01 Compositions comprising cefepime and tazobactam

Publications (1)

Publication Number Publication Date
PL2714034T3 true PL2714034T3 (pl) 2018-12-31

Family

ID=44681394

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11761404T PL2714034T3 (pl) 2011-05-28 2011-08-01 Kompozycje zawierające cefepim i tazobaktam

Country Status (18)

Country Link
US (1) US10525043B2 (pl)
EP (2) EP3412289A1 (pl)
JP (1) JP5767745B2 (pl)
KR (3) KR20170032480A (pl)
CN (2) CN109481439A (pl)
AU (1) AU2011369802B2 (pl)
BR (1) BR112013030282B1 (pl)
CA (1) CA2835907C (pl)
DK (1) DK2714034T3 (pl)
ES (1) ES2690725T3 (pl)
HU (1) HUE040049T2 (pl)
MX (1) MX356373B (pl)
NZ (1) NZ616692A (pl)
PL (1) PL2714034T3 (pl)
PT (1) PT2714034T (pl)
RU (1) RU2593363C2 (pl)
WO (1) WO2012164358A1 (pl)
ZA (1) ZA201307837B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3125887A1 (en) * 2014-03-29 2017-02-08 Wockhardt Limited Pharmaceutical compositions comprising cefepime or sulbactam
CN119280246A (zh) * 2016-03-31 2025-01-10 沃克哈特有限公司 抗菌组合物
MX2017013433A (es) * 2016-03-31 2018-01-30 Wockhardt Ltd Composiciones antibacterianas.
MX373853B (es) * 2016-03-31 2020-07-07 Wockhardt Ltd Composiciones antibacterianas y metodos.
JP6986089B2 (ja) 2017-10-05 2021-12-22 富士フイルム株式会社 新規な2−カルボキシペナム化合物またはその塩、それらを含有する医薬組成物およびその応用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1565456A (zh) * 2003-06-14 2005-01-19 张哲峰 一种头孢吡肟抗菌组合药物
CN1565455A (zh) * 2003-07-04 2005-01-19 成都博瑞医药科技开发有限公司 治疗产超广谱β-内酰胺酶细菌感染用的抗菌素组合物
RS51506B (sr) * 2004-12-02 2011-06-30 Venus Remedies Limited H. O&R&D. Smeše za suzbijanje beta-laktamazom posredovane rezistencije na antibiotike upotrebom inhibitora beta-laktamaze, korisne za injekcije
WO2007086014A1 (en) 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation comprising cefpirome, tazobactam and linezolid
WO2007086011A1 (en) 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation comprising cefepime, tazobactam and linezolid
EP1958630A1 (en) * 2007-02-13 2008-08-20 LEK Pharmaceuticals d.d. Antibacterial combination of a tricyclic carbapenem and an antibiotic
US20100197650A1 (en) * 2008-08-28 2010-08-05 Forest Laboratories Holdings Ltd. Compositions and methods of treatment comprising ceftaroline

Also Published As

Publication number Publication date
CN103608013A (zh) 2014-02-26
KR101850265B1 (ko) 2018-04-18
ES2690725T3 (es) 2018-11-22
PT2714034T (pt) 2018-10-30
ZA201307837B (en) 2015-01-28
AU2011369802B2 (en) 2016-09-08
KR20140035376A (ko) 2014-03-21
HUE040049T2 (hu) 2019-02-28
CA2835907A1 (en) 2012-12-06
CA2835907C (en) 2017-03-21
NZ616692A (en) 2015-07-31
EP2714034A1 (en) 2014-04-09
BR112013030282A2 (pt) 2017-11-07
MX356373B (es) 2018-05-25
KR20170032480A (ko) 2017-03-22
DK2714034T3 (en) 2018-10-08
BR112013030282B1 (pt) 2020-09-29
JP5767745B2 (ja) 2015-08-19
WO2012164358A1 (en) 2012-12-06
US10525043B2 (en) 2020-01-07
US20140162995A1 (en) 2014-06-12
CN109481439A (zh) 2019-03-19
MX2013013079A (es) 2013-12-06
EP2714034B1 (en) 2018-07-25
KR20180016645A (ko) 2018-02-14
RU2013157933A (ru) 2015-07-10
RU2593363C2 (ru) 2016-08-10
JP2014514305A (ja) 2014-06-19
AU2011369802A1 (en) 2013-10-31
EP3412289A1 (en) 2018-12-12

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
IL235436A0 (en) Anti-pcsk9 preparations and their use
IL252566B (en) Pharmacy preparations and methods
EP2646468A4 (en) ANTI-NGF COMPOSITIONS AND THEIR USE
IL236024A (en) The history of benzimidazole-proline and its pharmaceutical preparations
PT3366143T (pt) Composições e métodos probióticos
ZA201209259B (en) Uses and compositions
EP2797943A4 (en) COMPOSITIONS WITH C5 AND C6 MONOSACCHARIDES
SG11201402929YA (en) Compositions comprising gallates and gallamides
ZA201402167B (en) Compositions of lopinavir and ritonavir
ZA201307187B (en) Synergistic compositions and methods
EP2874641A4 (en) COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
GB201315350D0 (en) Methods and compositions
IL221087A (en) Pharmacy or nutritional composition
EP2668044A4 (en) COMPOSITIONS AND THEIR USE
ZA201308892B (en) Compositions and methods
GB201315347D0 (en) Methods and compositions
HUE040049T2 (hu) Cefepim és tazobaktam tartalmú készítmények
IL226554A (en) Medicinal preparations containing alisporiovir
GB201208315D0 (en) Pharmaceutical methods and compositions
PL2830587T3 (pl) Kompozycja o balansującym i ochronnym wpływie na skórę
GB201110598D0 (en) Pharmaceutical compositions and devices
GB201101924D0 (en) Compositions and uses
GB201107454D0 (en) Compositions and uses
GB201120470D0 (en) Compositions and uses thereof